author-photo

P. Sanchez Rovira

Aarhus University

14

Papers

1698

Citations

Citation Trend

Filter By

Papers (12) Sort By

Journal Conference Others

Abstract P3-09-08: Overeating and breast cancer risk by pathologic subtypes: EpiGEICAM study

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
P1.07-036 LC-HRMS Metabolomics Profiling in Advanced NSCLC Treated with Anti PD-1 Agents. Metabolic Features at Diagnosis and at Response Evaluation

2017 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P3-07-15: Prosigna® subtype correlation is a strong predictor of response to neoadjuvant chemotherapy (NAC) in early breast cancer (EBC) study

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Abstract P3-07-14: Prosigna® intrinsic subtyping predicts response to neoadjuvant combination therapy in study that includes herceptin within HER2+ (IHC) patients

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
1328 Lung cancer in very elderly adults: Outcomes of population under 80 in our institution

2015 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Final analysis of dose density with zoledronic acid treatment in metastatic breast cancer patients: ZARAS study.

2011 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Chemotherapy (CT) versus hormone therapy (HT) as neoadjuvant treatment in luminal breast cancer: A multicenter, randomized phase II study (GEICAM/2006-03).

2010 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (12)
Abstract P1-11-09: Predictive Response Factors (PRF) in an Open, Non-Randomized, Phase II Study of a Combination of Bevacizumab (BZ) and Sequential Chemotherapy as Preoperative Treatment in Patients with Operable HER-2 Negative Breast Cancer (BC)

2010 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Predictive response factors (PRF) in an open, nonrandomized, phase II study of a combination of bevacizumab (BZ) and sequential chemotherapy as preoperative treatment in patients with operable HER2-negative breast cancer (BC).

2010 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Treatment and prophylaxis of ifosfamide-induced encephalopathy with intravenous methylene blue

2006
Show All
- Source
- Cite
- Save
Citations (1)